NovaBridge Biosciences
F:0VY
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
NovaBridge Biosciences
F:0VY
|
US |
|
U
|
Unite Group PLC
XMUN:U1B
|
UK |
|
TomCo Energy PLC
F:NI41
|
UK |
|
K
|
Kongsberg Gruppen ASA
OSE:KOG
|
NO |
|
A
|
Altius Minerals Corp (AB)
XMUN:VTM
|
CA |
|
Carnival Corp
F:3B5
|
US |
|
Australian Industrial Minerals Ltd
OTC:AUMMF
|
AU |
|
V
|
Vhm Ltd
ASX:VHM
|
AU |
|
C
|
Chibougamau Independent Mines Inc
F:CLL1
|
CA |
|
S
|
Sixt SE
XMUN:SIX3
|
DE |
|
H
|
Hikma Pharmaceuticals PLC
F:H5P
|
UK |
|
ASR Nederland NV
F:A16
|
NL |
|
Tecsys Inc
TSX:TCS
|
CA |
|
S
|
Sixt SE
XHAM:SIX3
|
DE |
|
F
|
Fort St James Nickel Corp
XTSX:FTJ
|
CA |
|
Tallink Grupp AS
F:T5N
|
EE |
|
T
|
Tecsys Inc
OTC:TCYSF
|
CA |
|
Arch Biopartners Inc
XTSX:ARCH
|
CA |
|
P
|
PGT Holdings JSC
VN:PGT
|
VN |
|
Dino Polska SA
OTC:DNOPF
|
PL |
|
T
|
Tokyu Fudosan Holdings Corp
OTC:TKFOY
|
JP |
|
Zeda Ltd
F:LJ0
|
ZA |
|
G
|
Guangzhou R&F Properties Co Ltd
XMUN:G5HA
|
CN |
Bankruptcy Probability
NovaBridge Biosciences's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
NovaBridge Biosciences Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
NovaBridge Biosciences
NASDAQ:NBP
|
183.3m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
464.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
203.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
181.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
130.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
80B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
53.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
83.5B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
57.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
50.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
43.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
NovaBridge Biosciences's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, NovaBridge Biosciences has no debt.
You can find a full breakdown on its Balance Sheet.